Stanford University


Showing 1,141-1,150 of 7,843 Results

  • Paul Cheng MD PhD

    Paul Cheng MD PhD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.

    Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.

    Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu

  • Tiffany Cheng

    Tiffany Cheng

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    BioI am a physician leader and anesthesiologist at Stanford Health Care, where I serve as Medical Director of Perioperative Services at SHC Palo Alto and hold a faculty appointment as Clinical Assistant Professor at Stanford University School of Medicine.

    My work sits at the intersection of direct patient care and systems-level leadership. I have a track record of building high-performing clinical teams, designing governance structures from the ground up, and delivering measurable operational impact — including significant improvements in OR utilization, block efficiency, and access to care across Stanford's interventional platform.

    I founded Stanford's Anesthesiology Mentorship Program (AMP), a faculty development initiative that received the Augustus A. White III Award, and co-founded ASPIRE, a multi-institutional speaker exchange network. I am a graduate of Stanford's Physician Leadership Certificate Program and will begin an Executive MBA at Santa Clara University in Fall 2026.

    I believe that the strongest clinical institutions are built on trust, accountability, and a genuine investment in the people doing the work — and I bring that conviction to every leadership role I hold.

  • Xingxing Shelley Cheng

    Xingxing Shelley Cheng

    Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy

    Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
    1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
    2) ethics of and decision-making in in multi-organ transplantation.

  • David Cheriton

    David Cheriton

    Professor of Computer Science, Emeritus

    BioCheriton's research includes the areas of high-performance distributed systems, and high-speed computer communication with a particular interest in protocol design. He leads the Distributed Systems Group in the TRIAD project, focused on understanding and solving problems with the Internet architecture. He has also been teaching and writing about object-oriented programming, building on his experience with OOP in systems building.

  • Athena Cherry

    Athena Cherry

    Member, Stanford Cancer Institute

    Current Research and Scholarly InterestsThe use of molecular and molecular cytogenetic methods to identify chromosomal abnormalities in acquired and congenital disorders.

  • Mike Cherry

    Mike Cherry

    Professor (Research) of Genetics, Emeritus

    Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.